Overview

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and tolerability of multiple subcutaneous injections of various dosages of risperidone with clinically stable schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Risperidone